Olema Pharmaceuticals Inc (OLMA)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-03-03 | Ms. Shawnte M. MitchellChief Legal Officer & Corporate Secretary | -40.00k | 776.70k | Derivative Exercise and Sale | 4.37 - 24.69 | 0.00 | - |
| 2026-01-20 | Dr. Cyrus L. HarmonIndependent Director | -10.00k | 268.80k | 売り | 26.88 | 844.80k | -1.17% |
| 2026-01-14 | Dr. Cyrus L. HarmonIndependent Director | -3.49k | 101.60k | 売り | 29.12 | 854.80k | -0.41% |
| 2026-01-13 | Mr. Shane William Charles KovacsConsultant | -103.82k | 2.98M | 売り | 28.01 - 28.73 | 139.73k | -42.63% |
| 2026-01-13 | Dr. David C. MylesChief Scientific Officer | -100.00k | 2.34M | Derivative Exercise and Sale | 4.87 - 28.99 | 700.44k | - |
| 2026-01-12 | Dr. David C. MylesChief Scientific Officer | -10.00k | 283.40k | 売り | 28.34 | 700.44k | -1.41% |
| 2025-12-26 | Dr. Sean P. BohenPresident, CEO, Interim Principal Financial Officer & Director | -8.50k | 0.00 | Other Disposition | - | 237.65k | -3.45% |
| 2025-12-22 | Dr. Cyrus L. HarmonIndependent Director | -2.88k | 82.19k | 売り | 28.53 | 858.29k | -0.33% |
| 2025-12-19 | Mr. Ian T. ClarkIndependent Chairperson of the Board | -264.80k | 6.65M | Derivative Exercise and Sale | 3.61 - 30.48 | 0.00 | - |
| 2025-12-19 | Dr. David C. MylesChief Scientific Officer | -51.00k | 1.55M | 売り | 28.08 - 31.39 | 710.56k | -6.70% |
| 2025-12-19 | Dr. David C. MylesChief Scientific Officer | -9.00k | 0.00 | Other Disposition | - | 710.56k | -1.25% |
| 2025-12-19 | Dr. Naseem ZojwallaChief Medical Officer | -140.00k | 2.24M | Derivative Exercise and Sale | 7.02 - 28.04 | 4.49k | - |
| 2025-12-19 | Dr. Naseem ZojwallaChief Medical Officer | -129.51k | 3.62M | 売り | 27.66 - 28.93 | 4.49k | -96.65% |
| 2025-12-08 | Mr. Shane William Charles KovacsConsultant | -75.00k | 0.00 | Other Disposition | - | 243.55k | -23.54% |
| 2025-11-26 | Mr. Shane William Charles KovacsConsultant | -225.00k | 0.00 | Other Disposition | - | 318.55k | -41.39% |
| 2025-11-21 | Mr. Andrew S. RappaportIndependent Director | -35.87k | 13.99k | Derivative Exercise and Sale | - | 385.97k | - |
| 2025-09-16 | Dr. Cyrus L. HarmonIndependent Director | -25.00k | 204.84k | 売り | 8.04 - 8.33 | 861.17k | -2.82% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。